The DOI matches its Crossref record; 414 of the 414 references it cites were found in a registry or an index.
Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study
Open accessAbstract
Epigenetics regulates gene expression and has been confirmed to play a critical role in a variety of metabolic diseases, such as diabetes, obesity, non-alcoholic fatty liver disease (NAFLD), osteoporosis, gout, hyperthyroidism, hypothyroidism and others. The term ‘epigenetics’ was firstly proposed in 1942 and with the development of technologies, the exploration of epigenetics has made great progresses. There are four main epigenetic mechanisms, including DNA methylation, histone modification, chromatin remodelling, and noncoding RNA (ncRNA), which exert different effects on metabolic diseases. Genetic and non-genetic factors, including ageing, diet, and exercise, interact with epigenetics and jointly affect the formation of a phenotype. Understanding epigenetics could be applied to diagnosing and treating metabolic diseases in the clinic, including epigenetic biomarkers, epigenetic drugs, and epigenetic editing. In this review, we introduce the brief history of epigenetics as well as the milestone events since the proposal of the term ‘epigenetics’. Moreover, we summarise the research methods of epigenetics and introduce four main general mechanisms of epigenetic modulation. Furthermore, we summarise epigenetic mechanisms in metabolic diseases and introduce the interaction between epigenetics and genetic or non-genetic factors. Finally, we introduce the clinical trials and applications of epigenetics in metabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
8 retracted
Wang, T., Chen, K., Yao, W., Zheng, R., He, Q., Xia, J., Li, J., Shao, Y., Zhang, L. R., Huang, L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.028 · Cited by 111
Self-citationRetractedRETRACTED ARTICLE: Circular RNA circStag1 promotes bone regeneration by interacting with HuR
Chen, G., Long, C., Wang, S., Wang, Z., Chen, X., Tang, W., He, X., Bao, Z., Tan, B., Zhao, J., et al. (2022) · Bone Research · doi:10.1038/s41413-022-00208-x · Cited by 52
Self-citationRetractedKang, Z., Zhang, S., Jiang, E., Wang, X., Wang, Z., Chen, H., & Lan, X. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.09.011 · Cited by 48
RetractedYou, M., Ai, Z., Zeng, J., Fu, Y., Zhang, L., & Wu, X. (2022) · Bioengineered · doi:10.1080/21655979.2022.2067286 · Cited by 38
RetractedDai, Z., & Wei, G. (2022) · Bioengineered · doi:10.1080/21655979.2021.2015880 · Cited by 12
RetractedCao, Q., Zhang, X., Xie, F., Li, Y., & Lin, F. (2022) · Bioengineered · doi:10.1080/21655979.2022.2076982 · Cited by 10
RetractedTian, J., Pan, W., Xu, X., Tian, X., Zhang, M., & Hu, Q. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117724 · Cited by 9
RetractedHan, T., Li, W., Zhang, H., & Nie, D. (2022) · Bioengineered · doi:10.1080/21655979.2022.2062988 · Cited by 7
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Cited by
Epigenetics-targeted drugs: current paradigms and future challenges
Dai, W., Qiao, X., Fang, Y., Guo, R., Bai, P., Liu, S., Li, T., Jiang, Y., Wei, S., Na, Z., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02039-0 · Cited by 339
Akkız, H., Gieseler, R. K., & Canbay, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147873 · Cited by 191
Protein neddylation and its role in health and diseases
Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01800-9 · Cited by 171
Self-citationImmunopathogenic mechanisms and immunoregulatory therapies in MASLD
He, Y., Chen, Y., Qian, S., van Der Merwe, S., Dhar, D., Brenner, D. A., & Tacke, F. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01307-5 · Cited by 81
“Epigenetic regulation is a mechanism that modulates heritable gene expression without altering the DNA sequence and includes chromatin remodeling, histone modi fi cations, and noncoding RNA (ncRNA) regulation, among other mechanisms [108].”
Evaluation of pediatric epigenetic clocks across multiple tissues
Fang, F., Zhou, L., Perng, W., Marsit, C. J., Knight, A. K., Cardenas, A., Aung, M. T., Hivert, M.-F., Aris, I. M., Goodrich, J. M., et al. (2023) · Clinical Epigenetics · doi:10.1186/s13148-023-01552-3 · Cited by 33
Metadata
- Authors
- Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2023-03-02
- Volume
- 8
- Issue
- 1
- Pages
- 98-98
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4322770791
- Cited by
- 476
- References
- 414
- FWCI
- 35.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. https://app.cochat.ai/papers/10.1038/s41392-023-01333-7
- The paper
- Wu, Y.-L., Lin, Z.-J., Li, C.-C., Lin, X., Shan, S.-K., Guo, B., Zheng, M.-H., Li, F., Yuan, L.-Q., & Li, Z.-H. (2023). Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study. Signal Transduction and Targeted Therapy. https://doi.org/10.1038/s41392-023-01333-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.